Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Progesterone protects rat brain cells by enhancing GABA A receptor activity.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

PRP injections effectively improve stress urinary incontinence in women.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Provenge extends prostate cancer survival by about 4 months.

Angiogenesis can be controlled by balancing stimulators like VPF/VEGF and inhibitors like TSP.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Combining SVF and PRP speeds up wound healing.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Bridging anticoagulation may raise post-surgery bleeding risks.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

PRF and CGF are becoming more popular than PRP in regenerative medicine due to their simplicity and lack of additives.

Human placenta extract may promote hair growth by affecting certain lipid compounds.

PRP may help improve ovarian function, but more research is needed for consistent results.